[HTML][HTML] Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients

M Pistelli, M De Lisa, Z Ballatore, M Caramanti… - BMC cancer, 2015 - Springer
Background There is a growing body of evidence that immune response plays a large role
in cancer outcome. The neutrophil to lymphocyte ratio (NLR) has been used as a simple …

[HTML][HTML] Role of maspin in cancer

…, F Morgese, A Onofri, P Mazzanti, M Pistelli… - Clinical and translational …, 2013 - Springer
Maspin (mammary serine protease inhibitor), is a member of the serine protease inhibitor/non-inhibitor
superfamily. Its expression is down-regulated in breast, prostate, gastric and …

[HTML][HTML] Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations

M Pistelli, M Caramanti, T Biscotti, A Santinelli… - Cancers, 2014 - mdpi.com
Background: Triple-negative breast cancers (TNBC) are characterized by aggressive tumour
biology resulting in a poor prognosis. Androgen receptor (AR) is one of newly emerging …

5-Fluorouracil pharmacogenomics: still rocking after all these years?

…, E Maccaroni, R Giampieri, M Pistelli… - …, 2011 - Future Medicine
Mirco PistelliMirco Pistelli

[HTML][HTML] Risk of hyponatraemia in cancer patients treated with targeted therapies: a systematic review and meta-analysis of clinical trials

…, M Torniai, A Savini, I Fiordoliva, A Onofri, M Pistelli… - PLoS …, 2016 - journals.plos.org
Background Hyponatraemia has been reported with targeted therapies in cancer patients.
Aim of the study was to perform an up-to-date meta-analysis in order to determine the …

Prognostic factors in early-stage triple-negative breast cancer: lessons and limits from clinical practice

M Pistelli, A Pagliacci, N Battelli, A Santinelli… - Anticancer …, 2013 - ar.iiarjournals.org
Aim: Triple-negative breast cancer has a poor prognosis due to its aggressive behaviour and
lack of effective targeted therapies. We aimed to verify whether clinical and/or pathological …

[HTML][HTML] Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy

…, S Rinaldi, M Tiberi, F Morgese, M Torniai, M Pistelli… - Oncotarget, 2017 - ncbi.nlm.nih.gov
… Rossana Berardi, 1 Matteo Santoni, 1 Thomas Newsom-Davis, 2 Miriam Caramanti, 1
Silvia Rinaldi, 1 Michela Tiberi, 1 Francesca Morgese, 1 Mariangela Torniai, 1 Mirco Pistelli …

Pregnancy after breast cancer in young BRCA carriers: an international hospital-based cohort study

…, G Acconci, E Baldacci, G Bianchini, M Pistelli… - JAMA, 2024 - jamanetwork.com
Importance Young women with breast cancer who have germline pathogenic variants
inBRCA1orBRCA2face unique challenges regarding fertility. Previous studies demonstrating the …

Speckle-tracking global longitudinal strain as an early predictor of cardiotoxicity in breast carcinoma

…, M Morelli, E Piccolo, N Battelli, M Pistelli… - Supportive Care in …, 2016 - Springer
Purpose Recent development in anticancer therapies for breast carcinoma allowed an
improvement in patients’ survival, notwithstanding a parallel increase of cardiovascular morbidity. …

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real‐world evidence

…, MR Valerio, R Berardi, M Pistelli… - Journal of Cellular …, 2020 - Wiley Online Library
Body mass index (BMI) is a main indicator of obesity and its association with breast cancer
is well established. However, little is known in the metastatic setting, especially in HER2‐…